In the News

• Press Release
• |
• Tuesday, Feb 4 2020

SOURCE: CISION PR Newswire

Proteomics company CDI adds HuScan™ (PhIP-Seq patient biomarker discovery platform) and VirScan™ (PhIP-Seq antibody detection assays that includes every known human and viral protein).

• Press Release
• |
• Wednesday, Mar 6 2019

SOURCE: CISION PR Newswire

• Press Release
• |
• Tuesday, Mar 5 2019

SOURCE: CISION PR Newswire

Proteomics company now producing glass slides printed with recombinant human proteins containing over 21,000 human proteins and protein isoforms, including >81% of canonically expressed proteins as defined by the Human Protein Atlas for high through­put analytics, contract research and hybridoma development services.

• News
• |
• Thursday, Apr 19 2018

SOURCE: News is My Business

• Press Release
• |
• Wednesday, Mar 28 2018

SOURCE: CISION PR Newswire

Proteomics company leverages microarray capability to develop truly monospecific monoclonal antibodies

• Press Release
• |
• Thursday, Mar 8 2018

SOURCE: BioSpace

• Press Release
• |
• Tuesday, Nov 28 2017

SOURCE: CISION PR Newswire

Proteomics company's high-content proteome microarray gaining traction in disease diagnosis and prognosis.

• News
• |
• Wednesday, Nov 1 2017

SOURCE: Technology Networks - Proteomics and Metabolomics

Advancing Protein Biomarker Discovery

• Press Release
• |
• Thursday, May 25 2017

SOURCE: CISION PR Newswire

Proteomics company now producing glass slides printed with recombinant human proteins comprising 81% of the human proteome for high throughput analytics, contract research and hybridoma development services.

• Press Release
• |
• Monday, Apr 17 2017

SOURCE: CISION PR Newswire